0001209191-12-039152.txt : 20120726 0001209191-12-039152.hdr.sgml : 20120726 20120726164347 ACCESSION NUMBER: 0001209191-12-039152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120725 FILED AS OF DATE: 20120726 DATE AS OF CHANGE: 20120726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 12987880 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2012-07-25 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2012-07-25 4 M 0 4000 15.60 A 636895 D Common Stock 2012-07-25 4 S 0 1300 48.69 D 635595 D Common Stock 2012-07-25 4 S 0 2700 49.16 D 632895 D Common Stock 13286 I 401(k) Common Stock 300000 I Common Stock held in trust. Employee Stock Option (right to buy) 15.60 2012-07-25 4 M 0 4000 0.00 D 2013-01-17 Common Stock 4000 90951 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $48.69 (range $48.19 to $48.98). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $49.16 (range $49.00 to $49.34). Common stock held in grantor retained annuity trusts. Fully vested. Valerie L. Andrews, Attorney-In-Fact 2012-07-26